Cargando…
Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17
BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority among American policymakers. Elucidation of the sociodemographic and institutional differences associated with the use, or lack thereof, of opioid agonist therapy (OAT) provides greater clarity on who rec...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907755/ https://www.ncbi.nlm.nih.gov/pubmed/31830137 http://dx.doi.org/10.1371/journal.pone.0226349 |
_version_ | 1783478589305389056 |
---|---|
author | Yang, Justin C. Roman-Urrestarazu, Andres Brayne, Carol |
author_facet | Yang, Justin C. Roman-Urrestarazu, Andres Brayne, Carol |
author_sort | Yang, Justin C. |
collection | PubMed |
description | BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority among American policymakers. Elucidation of the sociodemographic and institutional differences associated with the use, or lack thereof, of opioid agonist therapy (OAT) provides greater clarity on who receives OAT. Timely access to care is a further consideration and bears scrutiny as well. METHODS: We draw upon data from the Treatment Episode Data Set—Admissions (TEDS-A) to analyse the relationship between sociodemographic and institutional characteristics and the receipt of opioid agonist treatments and time waiting to enter treatment. RESULTS: Estimates from logistic regression models highlight certain groups which show lower odds of receipt of OAT, including those in precarious housing arrangements, those unemployed or not otherwise in the labor force, and those referred by drug abuse care providers, educational institutions, employers, and the criminal justice system. Groups which showed higher odds of waiting over a week to enter treatment included those who were separated, divorced, or widowed, those working part-time, and those referred by drug abuse care providers, employers, and the criminal justice system. CONCLUSION: Given the efficacy of OAT and the adverse outcomes associated with long waiting times, coordinated effort is needed to understand why these differences persist and how they may be addressed through appropriate policy responses. |
format | Online Article Text |
id | pubmed-6907755 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-69077552019-12-27 Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17 Yang, Justin C. Roman-Urrestarazu, Andres Brayne, Carol PLoS One Research Article BACKGROUND: Access to adequate treatment for opioid use disorder (OUD) has been a high priority among American policymakers. Elucidation of the sociodemographic and institutional differences associated with the use, or lack thereof, of opioid agonist therapy (OAT) provides greater clarity on who receives OAT. Timely access to care is a further consideration and bears scrutiny as well. METHODS: We draw upon data from the Treatment Episode Data Set—Admissions (TEDS-A) to analyse the relationship between sociodemographic and institutional characteristics and the receipt of opioid agonist treatments and time waiting to enter treatment. RESULTS: Estimates from logistic regression models highlight certain groups which show lower odds of receipt of OAT, including those in precarious housing arrangements, those unemployed or not otherwise in the labor force, and those referred by drug abuse care providers, educational institutions, employers, and the criminal justice system. Groups which showed higher odds of waiting over a week to enter treatment included those who were separated, divorced, or widowed, those working part-time, and those referred by drug abuse care providers, employers, and the criminal justice system. CONCLUSION: Given the efficacy of OAT and the adverse outcomes associated with long waiting times, coordinated effort is needed to understand why these differences persist and how they may be addressed through appropriate policy responses. Public Library of Science 2019-12-12 /pmc/articles/PMC6907755/ /pubmed/31830137 http://dx.doi.org/10.1371/journal.pone.0226349 Text en © 2019 Yang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Yang, Justin C. Roman-Urrestarazu, Andres Brayne, Carol Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17 |
title | Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17 |
title_full | Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17 |
title_fullStr | Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17 |
title_full_unstemmed | Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17 |
title_short | Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17 |
title_sort | differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the united states, 2014-17 |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6907755/ https://www.ncbi.nlm.nih.gov/pubmed/31830137 http://dx.doi.org/10.1371/journal.pone.0226349 |
work_keys_str_mv | AT yangjustinc differencesinreceiptofopioidagonisttreatmentandtimetoentertreatmentforopioidusedisorderamongspecialtyaddictionprogramsintheunitedstates201417 AT romanurrestarazuandres differencesinreceiptofopioidagonisttreatmentandtimetoentertreatmentforopioidusedisorderamongspecialtyaddictionprogramsintheunitedstates201417 AT braynecarol differencesinreceiptofopioidagonisttreatmentandtimetoentertreatmentforopioidusedisorderamongspecialtyaddictionprogramsintheunitedstates201417 |